After the marathon-like challenge presented by the 16th International AIDS Conference held in Toronto a month prior--a challenge that tested the stamina of even the youngest and fittest of conference-goers--the 46th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), held September 27-30, 2006, in San Francisco, was a welcome relief in its staid and singular focus on the presentation of data offering insights into the challenges a variety of patients and their physicians are facing in the second decade of highly active antiretroviral therapy (HAART), as well as reviews of how to make optimal use of antiretroviral regimens constructed from within the existing HAART armamentarium. The big news at this year's ICAAC, however, was on the antiretroviral pipeline, with previews of how a new generation of drugs may help make the difference between life and death for countless millions of men, women, and children living with HIV/AIDS.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Afternoon aerobic and resistance exercise have limited impact on 24-h CGM outcomes in adults with type 1 diabetes: A secondary analysis.
Diabetes Res Clin Pract
July 2021
University of Alberta, Augustana Faculty, 4901- 46th Avenue, Camrose, AB T4V 2R3, Canada; Physical Activity and Diabetes Laboratory, Alberta Diabetes Institute, L-052, Li Ka Shing Centre for Health Research Innovation, 112 Street, Edmonton, AB T6G 2T9, Canada; Faculty of Kinesiology, Sport and Recreation, University of Alberta, 3-100 University Hall, Van Vliet Complex, Edmonton, AB T6G 2H9, Canada; Women and Children's Health Research Institute, ECHA 4-081, University of Alberta, 11405 87 Avenue NW, Edmonton, AB T6G 1C9, Canada. Electronic address:
Aims: This study examined post-exercise glycemic variability in individuals with type 1 diabetes after acute bouts of resistance (RE) and aerobic exercise (AE) compared to a no-exercise day (CON). We hypothesized that exercise days would have greater glucose variability (standard deviation - SD, coefficient of variation - CV), and less time in range (TIR), compared to CON.
Methods: A secondary analysis was conducted on previously collected data.
Temporal trends in multiple sclerosis prevalence and incidence in a large population.
Neurology
April 2018
From the Division of Neurology, Department of Medicine (D.L.R., K.M.K.), Dalla Lana School of Public Health (H.C., R.C.), and Department of Family and Community Medicine (J.C.K., K.T.), University of Toronto; St. Michael's Hospital (D.L.R., P.G.), Toronto; Institute for Clinical Evaluative Sciences (D.L.R., H.C., A.S.W., J.C.K., A.K.), Toronto; Public Health Ontario (H.C., R.C.), Toronto; Departments of Internal Medicine and Community Health Sciences (R.A.M.), Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba; and Toronto Western Family Health Team (K.T.), University Health Network, Toronto, Canada.
Objective: We sought to better understand the reasons for increasing prevalence of multiple sclerosis (MS) by studying prevalence in relation to incidence, mortality rates, sex ratio, and geographic distribution of cases.
Methods: We identified MS cases from 1996 to 2013 in Ontario, Canada, by applying a validated algorithm to health administrative data. We calculated age- and sex-standardized prevalence and incidence rates for the province and by census division.
After the marathon-like challenge presented by the 16th International AIDS Conference held in Toronto a month prior--a challenge that tested the stamina of even the youngest and fittest of conference-goers--the 46th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), held September 27-30, 2006, in San Francisco, was a welcome relief in its staid and singular focus on the presentation of data offering insights into the challenges a variety of patients and their physicians are facing in the second decade of highly active antiretroviral therapy (HAART), as well as reviews of how to make optimal use of antiretroviral regimens constructed from within the existing HAART armamentarium. The big news at this year's ICAAC, however, was on the antiretroviral pipeline, with previews of how a new generation of drugs may help make the difference between life and death for countless millions of men, women, and children living with HIV/AIDS.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!